Addus HomeCare Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Addus HomeCare Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	401	426	517	649	765	864	951	1,059	1,155	1,423
Cost of revenue	295	310	380	470	539	595	651	719	780	961
Gross profit	106	116	137	179	226	270	300	340	375	462
General and administrative	76.8	76.9	105	134	170	189	217	235	259	307
Operating expenses	90.9	90.6	114	144	182	204	231	249	272	323
Operating income	15.5	25.3	22.8	34.8	44.5	65.9	68.7	91	103	139
Interest expense	2.33	4.47	5.02	3.11	3.19	5.81	8.91	11.1	7.73	13.6
Interest income	2.81	0.07	2.59	1.52	0.62	0.27	0.34	1.48	4.39	2.44
Pre-tax income	16.2	21.1	20.4	33.2	41.9	60.4	60.2	81.3	99.4	127
Income tax	4.1	9.26	4.1	7.36	8.81	15.3	14.1	18.8	25.8	31.5
Net income	12.2	12	16.4	25.2	33.1	45.1	46	62.5	73.6	95.9
EBITDA	22.1	31.9	31.5	45.3	56.6	80.4	82.8	105	116	155
EPS, basic	0.94	1.04	1.36	1.83	2.12	2.87	2.90	3.91	4.33	5.31
EPS, diluted	0.94	1.03	1.33	1.77	2.08	2.81	2.84	3.83	4.23	5.22
Shares, basic (weighted)	12.8	11.5	12	13.8	15.6	15.7	15.9	16	17	18.1
Shares, diluted (weighted)	12.9	11.6	12.4	14.2	16	16.1	16.2	16.3	17.4	18.4

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	8.01	53.8	70.4	112	145	169	80	64.8	98.9	81.6
Receivables	117	93.5	98.3	150	133	137	126	115	123	152
Other current assets	1.26	3.6	3.2	2.4	2.18	6.17	1.99	2.23	7.83	7.36
Total current assets	131	156	176	269	288	324	223	200	260	269
Property, plant and equipment	6.65	7.49	10.7	12.2	19.7	18.5	21.2	24	24.7	25
Lease right-of-use assets				21.1	38	36	39	45.4	47.3	43.7
Goodwill	72.7	90.3	135	275	469	504	583	663	971	997
Intangible assets	15.3	16.6	23.8	57.1	71.5	64.3	72.2	92	110	102
Other non-current assets									1,128	1,143
Total assets	230	272	348	637	893	948	938	1,024	1,413	1,437
Accounts payable	4.49	7.38	12.2	19.6	23.7	19.4	22.1	26.2	27.2	16.8
Accrued liabilities	42.6	44.6	11.6	22.4	37.6	37.1	27.5	33.2	29	28.2
Short-term debt	2.53	3.1	0.06	0.73	0.97
Total current liabilities	49.6	55.1	61.5	87.5	144	118	131	145	156	149
Long-term debt	22.5	39.9	17.2	59.2	194	221	132	124	218	121
Lease liabilities				14.3	35.5	32.9	35.5	39.7	41.9	37.3
Other non-current liabilities		0.45	0.88	0.16	0.59	1.78	6.06	0.24	0.13	0.24
Total liabilities	72.1	95.4	79.6	161	374	373	304	318	442	352
Total debt	25	43	17.3	59.9	195	221	132	124	218	121
Paid-in capital	92.3	96	178	360	369	380	393	404	594	613
Retained earnings	65.5	80.3	90.8	116	149	194	240	303	376	472
Shareholders' equity	155	170	268	476	519	574	634	707	970	1,085
Total equity	155	170	268	476	519	574	634	707	970	1,085
Total liabilities and equity	230	272	348	637	893	948	938	1,024	1,413	1,437
Shares outstanding	13.1	11.6	13.1	15.6	15.8	15.9	16.1	16.2	18.1	18.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	12.2	12	16.4	25.2	33.1	45.1	46	62.5	73.6	95.9
Depreciation and amortization	6.65	6.66	8.64	10.6	12.1	14.5	14.1	14.1	13.5	16.4
Stock-based compensation	1.07	2.55	4.11	5.77	6.01	9.43	10.6	10.3	11.2	16.4
Deferred income tax	-1.33	2.47	-0.38	-1.06	-4.65	7.28	3.91	2.82	13.2	17.9
Change in receivables	-33.6	19.4	-0.7	-37.5	23.9	-3.92	20.6	15.7	22.1	-26.7
Change in payables	-0.78	1.1	4.24	4.64	2.16	-4.81	2.51	2.03	-1.91	-12.7
Cash from operations	-0.74	52.8	33.2	12	109	39.5	105	112	116	112
Capital expenditures	-1.71	-3.62	-5.35	-4.62	-6.83	-4.65	-8.3	-9.45	-6.05	-7.72
Acquisitions	-20	-24.4	-62.4	-184	-208	-37.4	-98.3	-110	-354
Cash from investing	-21.7	-24.3	-67.8	-189	-214	-42	-107	-119	-355	-32.5
Debt issued	25	45	60.4	19.6
Debt repaid	-0.94	-24.1
Stock issued	3.02	1.16	76.6	173	3.95	1.11	2.55	0	176	0
Cash from financing	26.4	17.2	51.2	218	138	26.3	-87.5	-8.18	272	-96.3
Net change in cash	3.91	45.7	16.7	41.3	33.4	23.8	-88.9	-15.2	34.1	-17.3
Free cash flow	-2.46	49.2	27.9	7.4	103	34.8	96.8	103	110	104
Interest paid	2.32	2.26	4.34	2.32	2.37	5.09	7.99	10.3	6.52	12.5
Income taxes paid	5.09	6.73	4.1	7.3	10.6	17.8	1.48	15	26.3	12.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $113.19 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.4%	Gross profit / revenue.
Operating margin	10.0%	Operating income / revenue.
EBITDA margin	11.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	9.5%	Pre-tax income / revenue.
Net margin	7.1%	Net income / revenue.
FCF margin	10.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.0%	Cash from operations / revenue.
Effective tax rate	25.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.2%	Net income / average total assets.
Return on invested capital (ROIC)	10.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.2%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	1.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	23.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	14.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	23.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	15.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	15.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	35.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	26.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	25.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	33.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	23.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	22.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	30.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	27.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	23.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	23.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	22.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	20.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-4.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	2.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	0.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-6.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	2.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	0.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	11.8%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	19.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	15.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	5.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.69x	Current assets / current liabilities.
Quick ratio	1.46x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.59x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.05x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	4.2%	Total debt / total assets.
Liabilities / assets	21.2%	Total liabilities / total assets.
Net debt	-$38.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.23x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	14.9x	Operating income / interest expense.
Working capital	$116.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	76.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$40.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.01x	Revenue / average total assets.
Fixed asset turnover	61.9x	Revenue / average property, plant and equipment.
Receivables turnover	10.2x	Revenue / average receivables.
Days sales outstanding	36 days	365 x average receivables / revenue.
Days payables	7 days	365 x average accounts payable / cost of revenue.
FCF conversion	147.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.70	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$79.93	Revenue / diluted weighted shares.
FCF per share	$8.38	Free cash flow / diluted weighted shares.
Operating cash flow per share	$8.79	Cash from operations / diluted weighted shares.
Book value per share	$61.48	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.18	Tangible book value / shares outstanding.
Cash per share	$5.33	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$2.11B	Share price x shares outstanding.
Enterprise value	$2.08B	Market cap + total debt - cash - short-term investments.
P/E	20.1x	Market cap / net income. Only when net income is positive.
P/S	1.43x	Market cap / revenue.
P/B	1.84x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	51.9x	Market cap / tangible book value, when positive.
P/FCF	13.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.0x	Market cap / cash from operations, when positive.
EV/Sales	1.41x	Enterprise value / revenue.
EV/EBIT	14.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	13.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.3%	Free cash flow / market cap.
Earnings yield	5.0%	Net income / market cap (the inverse of P/E).
PEG	0.89x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Addus HomeCare Corp's revenue in fiscal 2025?

Addus HomeCare Corp reported revenue of $1.42B for fiscal 2025, 23.2% higher than the year before.

Was Addus HomeCare Corp profitable in fiscal 2025?

Yes. Net income was $95.9M, a net margin of 6.7%.

How much free cash flow did Addus HomeCare Corp generate in fiscal 2025?

Cash from operations of $111.5M minus capital expenditures of $7.7M left free cash flow of $103.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Addus HomeCare Corp